Search research articles
Contact Us
Filters
Showing results (261-270 of 451) with videos related to
Page
of 46
Sort By:
Molecular Cancer Research : MCR
|
February 18, 2018
Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma
Jonas Blaes, Carina M Thomé, Philipp-Niclas Pfenning, et al.
BMC Cancer
|
April 11, 2024
Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07)
Maximilian Y Deng, Amanda Salviano da Silva, Pauline Carlotta Göller, et al.
Acta Neuropathologica Communications
|
June 27, 2025
Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort
Tom T Fischer, Kendra K Maaß, Pitithat Puranachot, et al.
Neurology
|
May 12, 2019
Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study
Martha Nowosielski, Thierry Gorlia, Jacoline E C Bromberg, et al.
Neuro-Oncology
|
June 4, 2019
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
Farshad Nassiri, Yasin Mamatjan, Suganth Suppiah, et al.
Acta Neuropathologica
|
December 22, 2016
Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas
Felix Sahm, Andrey Korshunov, Daniel Schrimpf, et al.
Neuro-Oncology
|
February 18, 2020
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma
Antje Wick, Tobias Kessler, Michael Platten, et al.
Acta Neuropathologica
|
April 24, 2023
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Justin Z Wang, Vikas Patil, Jeff Liu, et al.
Neuro-Oncology
|
December 11, 2023
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial
Maximilian Y Deng, Sybren L N Maas, Felix Hinz, et al.
Journal of Neuro-Oncology
|
July 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis
Anna-Luisa Luger, Sven König, Patrick Felix Samp, et al.
Page
of 46
Search research articles
Search
Showing results (261-270 of 451) with videos related to
Sort By:
Page
of 46
Molecular Cancer Research : MCR
|
February 18, 2018
Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma
Jonas Blaes, Carina M Thomé, Philipp-Niclas Pfenning, et al.
BMC Cancer
|
April 11, 2024
Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07)
Maximilian Y Deng, Amanda Salviano da Silva, Pauline Carlotta Göller, et al.
Acta Neuropathologica Communications
|
June 27, 2025
Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort
Tom T Fischer, Kendra K Maaß, Pitithat Puranachot, et al.
Neurology
|
May 12, 2019
Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study
Martha Nowosielski, Thierry Gorlia, Jacoline E C Bromberg, et al.
Neuro-Oncology
|
June 4, 2019
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
Farshad Nassiri, Yasin Mamatjan, Suganth Suppiah, et al.
Acta Neuropathologica
|
December 22, 2016
Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas
Felix Sahm, Andrey Korshunov, Daniel Schrimpf, et al.
Neuro-Oncology
|
February 18, 2020
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma
Antje Wick, Tobias Kessler, Michael Platten, et al.
Acta Neuropathologica
|
April 24, 2023
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Justin Z Wang, Vikas Patil, Jeff Liu, et al.
Neuro-Oncology
|
December 11, 2023
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial
Maximilian Y Deng, Sybren L N Maas, Felix Hinz, et al.
Journal of Neuro-Oncology
|
July 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis
Anna-Luisa Luger, Sven König, Patrick Felix Samp, et al.
Page
of 46